COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease

We report a subtype of immune‐mediated encephalitis associated with COVID‐19, which closely mimics acute‐onset sporadic Creutzfeldt–Jakob disease. A 64‐year‐old man presented with confusion, aphasia, myoclonus, and a silent interstitial pneumonia. He tested positive for SARS‐CoV‐2. Cognition and myo...

Full description

Saved in:
Bibliographic Details
Published inAnnals of clinical and translational neurology Vol. 8; no. 12; pp. 2314 - 2318
Main Authors Beretta, Simone, Stabile, Andrea, Balducci, Claudia, DiFrancesco, Jacopo C., Patruno, Adriana, Rona, Roberto, Bombino, Michela, Capraro, Cristina, Andreetta, Francesca, Cavalcante, Paola, Moda, Fabio, Citerio, Giuseppe, Foti, Giuseppe, Bogliun, Graziella, Ferrarese, Carlo
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.12.2021
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text
ISSN2328-9503
2328-9503
DOI10.1002/acn3.51479

Cover

More Information
Summary:We report a subtype of immune‐mediated encephalitis associated with COVID‐19, which closely mimics acute‐onset sporadic Creutzfeldt–Jakob disease. A 64‐year‐old man presented with confusion, aphasia, myoclonus, and a silent interstitial pneumonia. He tested positive for SARS‐CoV‐2. Cognition and myoclonus rapidly deteriorated, EEG evolved to generalized periodic discharges and brain MRI showed multiple cortical DWI hyperintensities. CSF analysis was normal, except for a positive 14‐3‐3 protein. RT‐QuIC analysis was negative. High levels of pro‐inflammatory cytokines were present in the CSF and serum. Treatment with steroids and intravenous immunoglobulins produced EEG and clinical improvement, with a good neurological outcome at a 6‐month follow‐up.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:2328-9503
2328-9503
DOI:10.1002/acn3.51479